Nebulizer is a device used for the treatment of cystic fibrosis, asthma, chronic obstructive pulmonary disease (COPD), and other respiratory diseases or disorders. Nebulizer turns the liquid medicine into a very fine vapor that a patient can inhale through the face mask or mouthpiece. It utilizes compressed air, oxygen, or ultrasonic power to transform the solutions and suspensions into little droplets of aerosol that are breathed from a mouthpiece of the device. They come in both the portable size one can carry with them and a bigger size that is intended to sit on the table and plug into the wall. Both nebulizers are built-up of a base that endure a small container for liquid medicine, and tube that attaches the air compressor to medicine container. The components of the nebulizer include tubing, air filters, and compressor for delivering the medication to the user in a vaporized form.
As per study, “Nebulizers Global Market Report 2020-30: Covid 19 Implications and Growth” the key companies operating in the global nebulizers market include Becton Dickinson and Company; Agilent Technologies; Koninklijke Philips N.V.; Covidien plc; Omron Corporation; GE Healthcare Ltd.; Briggs Healthcare; Allied Healthcare Products, Inc; PARI Pharma; Medline Industries Inc.; GF Health Products, Inc.; Invacare Corporation and among others. Nebulizer manufacturers are gradually more investing in smart nebulizers which can be used by children and adults. Smart and intelligent nebulizers are application empowered and connected with the smart-phones. Users of such sorts of nebulizers can adjust the nebulization rate, they can choose the most appropriate atomization strength referring to their own demand or doctor`s advice
Based on type, nebulizers market is segmented as ultrasonic nebulizer, pneumatic nebulizer and mesh nebulizer. Ultrasonic nebulizer segment dominates the global market owing to reduced size of drug droplets. Additionally, mesh nebulizers is expected to witness higher growth rate due to growth in patient acceptance for mesh nebulizers and its accurate drug delivery during the forecast period. This segment is further sub-segmented as active mesh nebulizers and passive mesh nebulizers. In addition, based on application, market is segmented as Cystic Fibrosis, COPD, asthma and others.
The nebulizers market is driven by rise in demand for home healthcare devices, followed by growth in need for rescue medication, increase in incidence of chronic respiratory diseases and growth in geriatric population base coupled with increase in use of portable nebulizers. Increasing number of smokers and environmental pollution has led to growing chronic respiratory diseases which are likely to increase the demand for nebulizers. However, availability of nebulizer substitute and drug loss during drug delivery may impact the market. Moreover, increase in consumption of alcohol, cigarettes, tobacco, and other such products is a key opportunity for market.
Based on geography, the North-America region holds major share in global nebulizers market owing to continuous innovations in technology and increase in government initiatives in the region. The Asia-Pacific and Europe regions are estimated to exhibit substantial growth rate due to huge number of patients diagnosed with chronic respiratory conditions, and growth in economy over the forecast period. It is projected that future of the global nebulizers market will be bright because of increase in investment of healthcare infrastructure during the forecast period.
For More Information, Click on the Link Below:-
Ankur Gupta, Head Marketing & Communications